Literature DB >> 1618463

Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure.

S D Lidofsky1, N M Bass, M C Prager, D E Washington, A E Read, T L Wright, N L Ascher, J P Roberts, B F Scharschmidt, J R Lake.   

Abstract

Cerebral edema and intracranial hypertension, commonly present in fulminant hepatic failure, may lead to brainstem herniation and limit the survival of comatose patients awaiting liver transplantation before a donor organ becomes available. Also, they are likely responsible for postoperative neurological morbidity and mortality. Although intracranial pressure monitoring has been proposed to aid clinical decision making in this setting, its use in the prevention of brainstem herniation preoperatively, in the selection of patients for liver transplantation who have the potential for neurological recovery and in the maintenance of cerebral perfusion during liver transplantation has not been examined in detail. To address these issues, we established a protocol for intracranial pressure monitoring in comatose patients with fulminant hepatic failure as part of their preoperative and intraoperative management. Twenty adults and three children underwent intracranial pressure monitoring. Ten patients required preoperative medical therapy with mannitol, barbiturates or both for a rise in intracranial pressure above 25 mm Hg. Four patients had a sustained lowering of intracranial pressure, three of whom survived hospitalization. Six patients had intracranial hypertension refractory to medical management, were removed from a waiting list for a donor organ and died with brainstem herniation. Of the remaining 17 patients, 3 died of other causes while awaiting a donor organ, 2 recovered spontaneously without neurological sequelae and 12 underwent liver transplantation. All but one patient undergoing liver transplantation had transient intraoperative intracranial hypertension develop, requiring medical treatment. The 12 patients who had transplants recovered neurologically and were discharged from the hospital.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1618463     DOI: 10.1002/hep.1840160102

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  27 in total

1.  A Macaca mulatta model of fulminant hepatic failure.

Authors:  Ping Zhou; Jie Xia; Gang Guo; Zi-Xing Huang; Qiang Lu; Li Li; Hong-Xia Li; Yu-Jun Shi; Hong Bu
Journal:  World J Gastroenterol       Date:  2012-02-07       Impact factor: 5.742

2.  Needle exchange programmes should do more to prevent transmission of hepatitis C virus.

Authors:  C Ford
Journal:  BMJ       Date:  1996-09-21

Review 3.  Perioperative monitoring in liver transplant patients.

Authors:  Shweta Singh; Vaibhav Nasa; Manish Tandon
Journal:  J Clin Exp Hepatol       Date:  2012-09-21

Review 4.  Acute liver failure and liver transplantation.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara; Norihiro Kokudo
Journal:  Intractable Rare Dis Res       Date:  2013-08

5.  Outcomes and complications of intracranial pressure monitoring in acute liver failure: a retrospective cohort study.

Authors:  Constantine J Karvellas; Oren K Fix; Holly Battenhouse; Valerie Durkalski; Corron Sanders; William M Lee
Journal:  Crit Care Med       Date:  2014-05       Impact factor: 7.598

Review 6.  Neurological management of fulminant hepatic failure.

Authors:  Jennifer A Frontera; Thomas Kalb
Journal:  Neurocrit Care       Date:  2011-04       Impact factor: 3.210

Review 7.  Therapeutic hypothermia for acute liver failure: toward a randomized, controlled trial in patients with advanced hepatic encephalopathy.

Authors:  R Todd Stravitz; William M Lee; Andreas H Kramer; David J Kramer; Linda Hynan; Andres T Blei
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

8.  Management of hepatic encephalopathy.

Authors:  Jennifer A Frontera
Journal:  Curr Treat Options Neurol       Date:  2014-06       Impact factor: 3.598

9.  Neurogenic diabetes insipidus presenting in a patient with subacute liver failure: a case report.

Authors:  Manu Shankar Hari; Anthony K Parsons; Andy K Burroughs; Steve Shaw; James O'Beirne; Banwari Agarwal
Journal:  J Med Case Rep       Date:  2010-07-30

Review 10.  Clinical application of bioartificial liver support systems.

Authors:  Maarten Paul van de Kerkhove; Ruurdtje Hoekstra; Robert A F M Chamuleau; Thomas M van Gulik
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.